UBS Maintains a 'Neutral' on Molina Healthcare (MOH); Raising PT & Estimates
Tweet
Share
E-mailGet Alerts MOH Hot Sheet
Price: $212.43 +3.27%
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
11 Buy, 19 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Neutral' on Molina Healthcare (NYSE: MOH) price target raised from $22 to $31.
UBS analyst says, "We modestly increase our FY’12 EPS estimate to $1.82 (vs. $1.80 guidance), up from our prior $1.75 estimate and representing 17% YoY growth. Our Price Target is increased to $31 (from $22) and is based on a target multiple (~17x) in-line with its Medicaid peers which we now see as warranted given the diminished uncertainty for Molina’s key Washington state market post RFP awards in mid-Jan as well as Molina’s above-average exposure to states (CA/MI) that are likely to be among the first to transition a significant amount of its Dual Eligibles to Managed Care."
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $29.60 yesterday.
UBS analyst says, "We modestly increase our FY’12 EPS estimate to $1.82 (vs. $1.80 guidance), up from our prior $1.75 estimate and representing 17% YoY growth. Our Price Target is increased to $31 (from $22) and is based on a target multiple (~17x) in-line with its Medicaid peers which we now see as warranted given the diminished uncertainty for Molina’s key Washington state market post RFP awards in mid-Jan as well as Molina’s above-average exposure to states (CA/MI) that are likely to be among the first to transition a significant amount of its Dual Eligibles to Managed Care."
For an analyst ratings summary and ratings history on Molina Healthcare click here. For more ratings news on Molina Healthcare click here.
Shares of Molina Healthcare closed at $29.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- UBS Reiterates Buy Rating on HF Sinclair (DINO)
- Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
